Accelerate Dx 2013 Revenues Down 8 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics said in a document filed with the US Securities and Exchange Commission on Friday that revenues for 2013 were down 8 percent year over year.

The Tucson, Ariz.-based company did not break out revenues for the fourth quarter but based on previously disclosed financial figures for the first three quarters of the year, revenues for Q4 2013 were down 18 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.